Home/ economie ECONOMIEUnited States: FDA rejects Chinese cancer drugThe FDA rejected Ivonescimab by Summit, a cancer drug developed in China.Published 25m·1 sourceNotable Lire en françaisListen≈ 8sSpeed0.8×1×1.2×1.5×🔗Click the link to read an article on the topic:Financial Times↗🧭Explore this topicÉtats-UnisChineFDASummit#États-Unis#Chine#médicament anticancéreux#FDA#biotechnologieWhat if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.→Follow topic →↗ Share the newsAuto-synthesis from 1 media source · identified on November 15, 2026← Back to home